CEL-SCI Market Cap

CEL-SCI has a market cap or net worth of $47.93 million as of January 7, 2026. Its market cap has increased by 25.80% in one year.

Market Cap

47.93M

Enterprise Value

51.31M

1-Year Change

25.80%

Ranking

#4544

Market Cap Chart

Since December 1, 1998, CEL-SCI's market cap has increased from $27.40M to $47.93M, an increase of 74.93%. That is a compound annual growth rate of 2.08%.

Market Cap History

Date	Market Cap	% Change
Jan 6, 2026	52.90M	19.68%
Dec 31, 2025	44.20M	79.67%
Dec 31, 2024	24.60M	-81.90%
Dec 29, 2023	135.90M	32.46%
Dec 30, 2022	102.60M	-66.58%
Dec 31, 2021	307.00M	-33.78%
Dec 31, 2020	463.60M	43.22%
Dec 31, 2019	323.70M	297.18%
Dec 31, 2018	81.50M	226.00%
Dec 29, 2017	25.00M	96.85%
Dec 30, 2016	12.70M	-73.60%
Dec 31, 2015	48.10M	-9.42%
Dec 31, 2014	53.10M	80.61%
Dec 31, 2013	29.40M	-60.16%
Dec 31, 2012	73.80M	10.81%
Dec 30, 2011	66.60M	-60.45%
Dec 31, 2010	168.40M	25.11%
Dec 31, 2009	134.60M	300.60%
Dec 31, 2008	33.60M	-42.37%
Dec 31, 2007	58.30M	27.85%
Dec 29, 2006	45.60M	25.27%
Dec 30, 2005	36.40M	-15.74%
Dec 31, 2004	43.20M	-37.39%
Dec 31, 2003	69.00M	845.21%
Dec 31, 2002	7.30M	-67.12%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	967.33B
Johnson & Johnson	499.57B
AbbVie	405.28B
UnitedHealth Group	304.72B
AstraZeneca	284.35B
Novartis AG	266.00B
Merck & Co.	264.21B
Novo Nordisk	230.76B

Market Cap Rankings